Mangani D, Subramanian A, Huang L, et al. Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state. Immunity. 2024. doi:10.1016/j.immuni.2024.09.017
Jeong S, Tsai MJ, Shen C, Hsu YH. Falls, fracture and frailty risk in multiple sclerosis: a Mendelian Randomization study to identify shared genetics. Journal of bone and mineral metabolism. 2024. doi:10.1007/s00774-024-01504-8
Tanasescu R, Frakich N, Chou IJ, et al. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023. doi:10.1007/s40120-023-00539-9
Rojo D, Dal Cengio L, Badner A, et al. BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep. Neuron. 2023. doi:10.1016/j.neuron.2023.08.002
Dhand A, White CC, Johnson C, Xia Z, De Jager PL. A scalable online tool for quantitative social network assessment reveals potentially modifiable social environmental risks. Nat Commun. 2018;9(1):3930. doi:10.1038/s41467-018-06408-6
De Jager PL. Is the goal of an epigenomic study to determine causality?. Mult Scler. 2018;24(7):908-909. doi:10.1177/1352458517750771
Quintana FJ, Prinz M. A gut feeling about multiple sclerosis. Proc Natl Acad Sci U S A. 2017;114(40):10528-10529. doi:10.1073/pnas.1714260114
Manousaki D, Dudding T, Haworth S, et al. Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis. Am J Hum Genet. 2017;101(2):227-238. doi:10.1016/j.ajhg.2017.06.014
Felsky D, Patrick E, Schneider JA, et al. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018;13(1):38. doi:10.1186/s13024-018-0272-6
Kowalec K, Wright GEB, Drögemöller BI, et al. Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis. Nat Genet. 2018;50(8):1081-1085. doi:10.1038/s41588-018-0168-y